Analysis of Drug Use and Risk Factors for Type 2 Diabetes Mellitus at Community Health Center X in Medan City
DOI:
https://doi.org/10.35451/c1mkd495Keywords:
Diabetes, Community health center, FINDRISC, Risk factors, RationalityAbstract
Background: Type 2 diabetes mellitus (T2DM) is defined as a disorder of the metabolic system with incidence rates showing a continuous upward trend in both developed and developing countries such as Indonesia. Objective: This study aims to determine the profile of antidiabetic drug use and risk factors associated with T2DM incidence at Community Health Center X in Medan City. Methode: The research methodology used an observational design with an analytical nature through a cross-sectional approach. Sampling was conducted based on the medical records of T2DM patients through purposive sampling, and 50 patients were obtained as respondents by filling out the Finnish Diabetes Risk Questionnaire (FINDRISC). Data analysis was conducted at the univariate level, followed by the bivariate level using the Mann-Whitney and Chi-square tests, and continued at the multivariate level through FINDRISC logistic regression. Result: The FINDRISC questionnaire results in the high risk factor category (n=22; 44%) were due to increasing age, body mass index (BMI), waist circumference, consumption of hypertension medication, and KGD. The use of T2DM drugs was mostly metformin (51.7%) and glimepiride (39.3%), but no insulin was given (HbA1c>9.0%). Conclusion The use of antidiabetic drugs at Community Health Center X in Medan City is generally not in accordance with the guidelines and algorithms for T2DM therapy (PERKENI, 2015) because none of the patients received insulin therapy (n=50) where (HbA1c=7.4-10.7%), (GDS=210-360 mg/dL), (GDP=110-200 mg/dL) with a disease duration of (3-15) years. This is due to patients' fear (stigma) of using insulin. This situation emphasizes the importance of intensive education by healthcare workers to T2DM patients to increase acceptance of insulin therapy according to indications, thereby improving treatment effectiveness and reducing the risk of complications.
Downloads
References
1. Arania R, Triwahyuni T, Prasetya T, Cahyani SD. Hubungan antara pekerjaan dan aktivitas fisik dengan kejadian diabetes mellitus di Klinik Mardi Waluyo Kabupaten Lampung Tengah. J Medika Malahayati. 2021;5(3):163–9. doi:10.33024/jmm.v5i3.4110
2. Amalia L, Mokodompis Y, Ismail GA. Hubungan overweight dengan kejadian diabetes mellitus tipe 2 di wilayah kerja Community Health Center Bulango Utara. Jambura J Epidemiol. 2022;1(1):11–9. doi:10.37905/jje.v1i1.14623
3. Borchardt RT. Journal of Pharmaceutical Sciences. J Pharm Sci. 2008;97(6):2011. doi:10.1002/jps.21263
4. Trisnawati S, Widarsa IKT, Suastika K. Laporan hasil penelitian faktor risiko diabetes mellitus tipe 2 pasien rawat jalan di Community Health Center wilayah Kecamatan Denpasar Selatan. South Denpasar; [n.d.].
5. Ulfa AM, Angin MP, Azizah FN. Rasionalitas penggunaan obat antidiabetes melitus tipe II komplikasi hipertensi pada pasien rawat inap di Rumah Sakit Pertamina Bintang Amin tahun 2020. J Ilmu Kedoktoren Kesehatan. 2022;9(3):945–52. doi:10.33024/jikk.v9i3.5636
6. Dwi Arini H, Agung A, Putri AD, Yuliawati AN. Hubungan tingkat pendidikan dengan kepatuhan minum obat antidiabetes oral pada pasien diabetes melitus tipe 2. J Ilm Mahaganesha. 2023;2(Des):29–36.
7. Haryono DA, Arifin S, Shinta HE, Widodo T, Yuliani NNS. Hubungan obesitas dan aktivitas fisik dengan kejadian diabetes melitus tipe II pada usia >40 tahun di wilayah kerja Community Health Center Bukit Hindu. Barigas J Riset Mahasiswa. 2024;1(2):53–60. doi:10.37304/barigas.v1i2.7987
8. Isnaini N, Ratnasari R. Faktor risiko mempengaruhi kejadian diabetes mellitus tipe dua. J Kebidanan Keperawatan Aisyiyah. 2018;14(1):59–68. doi:10.31101/jkk.550
9. Lestari Z, Sijid, Aisyah ST. Diabetes melitus: review etiologi, patofisiologi, gejala, penyebab, cara pemeriksaan, cara pengobatan dan cara pencegahan. UIN Alauddin Makassar. 2021;1(2):237–41. Available from: http://journal.uin-alauddin.ac.id/index.php/psb
10. Lisnawati N, Kusmiyati F, Herwibawa B, Kristanto BA, Rizkika A. Hubungan indeks massa tubuh, persen lemak tubuh, dan aktivitas fisik dengan kadar gula darah remaja. J Nutr Coll. 2023;12(2):168–78. doi:10.14710/jnc.v12i2.36662
11. Milita F, Handayani S, Setiaji B. Kejadian diabetes mellitus tipe II pada lanjut usia di Indonesia (analisis Riskesdas 2018). J Kedokt Kesehat. 2021;17(1):9–20. doi:10.24853/jkk.17.1.9-20
12. Nathaniel S, Kahanjak DN, Mutiasari D. Literature review: hubungan indeks massa tubuh terhadap kadar gula darah diabetes melitus tipe 2. Galenical J Kedokt Kesehat Mahasiswa Malikussaleh. 2025;4(2):45–60. doi:10.29103/jkkmm.v4i2.21508
13. Perkeni. Pengelolaan dan pencegahan diabetes mellitus tipe 2 di Indonesia. Jakarta: Perkeni; 2015. p.46.
14. Perkeni. Pedoman pemantauan glukosa darah mandiri. Jakarta: PB Perkeni; 2021. p.49. Available from: https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-Website-Pedoman-Pemantauan-Glukosa-Darah-Mandiri-Ebook.pdf
15. Rosalinda J, Nugraheni AY. Faktor-faktor yang mempengaruhi tingkat kepatuhan pengobatan pasien diabetes melitus tipe 2 di Community Health Center Kotagede II Yogyakarta. Health Inf J Penelit (HIJP). 2023;15(2):1–16.
16. Septyaningrum N, Martini S. Lingkar perut mempunyai hubungan paling kuat dengan kadar gula darah. J Berkala Epidemiol. 2014;2(1):48–58.
17. Suardhika IM, Warnaya PCI, Budiartha PBPP, Arwanawati NNSM, Sarasmita MA. Evaluasi efektivitas biaya penggunaan terapi kombinasi obat antidiabetes-antihipertensi pada pasien diabetes mellitus tipe 2 dengan hipertensi di RSUP Sanglah. J Farm Udayana. 2020;9(1):27–34. doi:10.24843/jfu.2020.v09.i01.p04
18. Sari GP, Samekto M, Adi MS. Faktor-faktor yang berpengaruh terhadap terjadinya hipertensi pada penderita diabetes melitus tipe II (Studi di wilayah Community Health Center Kabupaten Pati). J Litbang Media Inform Penelit Pengemb IPTEK. 2017;13(1):47–59.
19. García-Rivera EJ, Ruiz-Serrano K, Miranda EI, Mejía LC, Pinzón A, Marqués-Goyco C, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus living in Puerto Rico. J Multimorb Comorb. 2024;14:1–12. doi:10.1177/26335565231224570
20. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–84. doi:10.1016/j.cjca.2017.12.005
21. Pop C, Petriş AO, Pop L, David LE. Pillars of blood pressure management in patients with type 2 diabetes mellitus: insights from recent trials and emerging perspectives. J Clin Med. 2025;14(10):1–14. doi:10.3390/jcm14103269
22. Savitri F, Savitri IK, Samodro P, Rujito L. Perbedaan profil lipid dan kadar asam urat pada pasien diabetes melitus tipe II dengan dan tanpa hipertensi. Scripta Biologica. 2017;4(3):189. doi:10.20884/1.sb.2017.4.3.425
23. Hasibuan ZM, AP. Sosialisasi penerapan indeks massa tubuh (IMT) di Suta Club. Cerdas Sifa Pendidikan. 2021;10(2):84–9. doi:10.22437/csp.v10i2.15585
Downloads
Published
Issue
Section
License
Copyright (c) 2026 apt. Salmah Handayani Lubis, S.Farm., M.Si., Dr. apt. Eva Sartika Dasopang, S.Farm.,M.Si., Fitri Wahyuni Siddik, S.Farm, Asnarita Ambarita
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright in each article is the property of the Author.
